10 ML crizanlizumab-tmca 10 MG/ML Injection

RxCUI: 2262425
RxNorm name: 10 ML crizanlizumab-tmca 10 MG/ML Injection
Display name: 10 ML crizanlizumab-tmca 10 MG/ML Injection
Full name: 10 ML crizanlizumab-tmca 10 MG/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761128	Adakveo	crizanlizumab-tmca	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ADAKVEO	CRIZANLIZUMAB	Novartis Pharmaceuticals Corporation	b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6	2026-06-04	Warnings, Adverse reactions	Exact identifier rxcui: 2262425

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6	10 ML crizanlizumab-tmca 10 MG/ML Injection	SCD	7	These highlights do not include all the information needed to use ADAKVEO safely and effectively. See full prescribing information for ADAKVEO. ADAKVEO ® (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019	20250603
b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6	crizanlizumab-tmca 100 MG in 10 ML Injection	PSN	7	These highlights do not include all the information needed to use ADAKVEO safely and effectively. See full prescribing information for ADAKVEO. ADAKVEO ® (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019	20250603
b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6	crizanlizumab-tmca 100 MG per 10 ML Injection	SY	7	These highlights do not include all the information needed to use ADAKVEO safely and effectively. See full prescribing information for ADAKVEO. ADAKVEO ® (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019	20250603